Cancer Research
-
CAR T-cell exhaustion switch found, disabled in mice study
In a breakthrough discovery, a team of researchers from Columbia University and University Hospital Tubingen has identified a key molecular switch responsible…
-
Study Reveals Hidden Tumors May Be More Vulnerable to Immune Attack
Michigan, June 6, 2026 — cybernewschronicle.com — Cancer cells that go invisible to the immune system might have just painted a target…
-
Cancer Cells Hiding From Killer T Cells Become Targets for Helper T Cells
For decades, the prevailing view in oncology held that cancer cells that lose MHC class I molecules become invisible to cytotoxic CD8⁺…
-
Scientists Capture 3D View of T Cells Attacking Cancer
Geneva, 5 June – A team of researchers from the University of Geneva and the CHUV/UNIL collaboration has produced the first detailed…
-
Abbott Buys Exact Sciences in $21B Cancer Deal
MADISON, Wis. — The stool DNA test sits in a box. Patients collect a sample at home, mail it to a lab,…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
Grail spin-out from Illumina completed June 2024 after EU regulatory order
June 29, 2024 — cyberinktimes.com — On June 24, 2024, a significant development occurred in the biotechnology sector as GRAIL, Inc., a…
-
Moderna’s KRAS Cancer Vaccine Candidate Was Dropped by Merck After Phase 1 Enrollment
In the realm of cancer research, the tetravalent vaccine candidate, code-named V941 or mRNA-5671, developed by Moderna, continues to garner attention within…
-
AbbVie to Acquire ImmunoGen for $10.1 Billion, Adding Ovarian Cancer Drug Elahere
On a Wednesday in mid-November, AbbVie decided it would pay $10.1 billion for ImmunoGen. That is a lot of money for a…
-
Talquetamab Wins FDA Accelerated Approval, Then European Approval, for Relapsed Multiple Myeloma
United States, August 16, 2023 — cybernewschronicle.com — On August 15, 2023, the medical community marked a significant milestone with the approval…
-
City of Hope Drug AOH1996 Moves Through Early Human Trial After Mouse Study Results
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
New Studies Show Immunotherapy Gaining Ground in Lung, Prostate and Childhood Cancers
-
Why Broad RAS-Targeting Drugs Mark a Turning Point in Treating Pancreatic Cancer
-
How At-Home Igalmi Differs From Traditional Treatments for Schizophrenia and Bipolar Agitation
-
Boron Neutron Capture Therapy Faces US Coverage Hurdles Over Cost and Data Gaps
-
FDA Proposes Slashing Companion Diagnostic Fees From $636,732 to $28,653
-
Biocon’s Pebrilzo FDA Approval Cements Its Role in Affordable Cancer Care
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992












